Wells Fargo & Company Seelos Therapeutics, Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.16 - $1.64 $8 - $85	52 Added 0.17%	30,929 $5,000
Q2 2023 Aug 15, 2023	BUY	$0.66 - $1.22 $89 - $165	136 Added 0.44%	30,877 $37,000
Q1 2023 May 12, 2023	BUY	$0.59 - $1.04 $6 - $11	11 Added 0.04%	30,741 $21,000
Q4 2022 Feb 13, 2023	SELL	$0.66 - $259.46 $5,265 - $2.07 Million	-7,978 Reduced 20.61%	30,730 $20,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $1 - $557	-2 Reduced 0.01%	38,708 $40,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $10,957 - $19,981	-21,486 Reduced 35.69%	38,710 $26,000
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $28,782 - $58,593	-34,265 Reduced 36.27%	60,196 $51,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $89,704 - $134,274	56,418 Added 148.3%	94,461 $154,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $64,292 - $109,944	38,043 New	38,043 $92,000
Q2 2021 Aug 16, 2021	SELL	$2.64 - $6.32 $1,111 - $2,660	-421 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.35 - $4.99 $542 - $2,005	-402 Reduced 48.85%	421 $2,000
Q4 2020 Feb 09, 2021	BUY	$0.74 - $2.01 $49 - $134	67 Added 8.86%	823 $2,000
Q3 2020 Nov 05, 2020	BUY	$0.6 - $1.25 $24 - $51	41 Added 5.73%	756 $0
Q2 2020 Aug 13, 2020	BUY	$0.42 - $1.51 $215 - $773	512 Added 252.22%	715 $1,000
Q1 2020 May 14, 2020	BUY	$0.47 - $1.56 $95 - $316	203 New	203 $0

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.